Markets:

Overview

News

Currencies

International

Treasuries

Galapagos NV - American Depositary Shares (NQ:GLPG)

31.59 -0.18 (-0.57%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 5, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Galapagos NV - American Depositary Shares

< Previous 1 2 3 4 Next >

Where Galapagos Stands With Analysts ↗

June 12, 2023

Via Benzinga

JP Morgan Maintains Neutral Rating for Galapagos: Here's What You Need To Know ↗

May 31, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 8, 2023 ↗

May 08, 2023

Via Benzinga

Earnings Outlook For Galapagos ↗

May 03, 2023

Via Benzinga

BigCommerce, ContextLogic And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

February 24, 2023

U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Earnings Preview For Galapagos ↗

February 23, 2023

Via Benzinga

Where Galapagos Stands With Analysts ↗

November 07, 2022

Galapagos (NASDAQ:GLPG) has observed the following analyst ratings within the last quarter:

Via Benzinga

Where Galapagos Stands With Analysts ↗

September 09, 2022

Analysts have provided the following ratings for Galapagos (NASDAQ:GLPG) within the last quarter:

Via Benzinga

Galapagos' Blood Cancer Candidate Shows 100% Objective Response Rate In Relapsed/Refractory Patients ↗

February 10, 2023

Via Benzinga

Why Galapagos Stock Is Falling Today ↗

February 09, 2023

Galapagos NV (NASDAQ: GLPG) announced the topline results from the DIVERSITY Phase 3 trial of filgotinib during induction and maintenance treatment of biologic-naïve and biologic-experienced patients...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 23, 2023 ↗

January 23, 2023

Via Benzinga

Galapagos Bets €225M On CellPoint Marking Its Entry Into CAR-T Field ↗

June 22, 2022

Via Benzinga

Galapagos In-licenses Inflammatory Bowel Disease Drug Targets From Scipher Medicine ↗

May 24, 2022

Via Benzinga

Twitter Rolls Out 'Blue For Business,' Visa Pitches Auto-Payments On Ethereum Blockchain, Justin Bieber Slams H&M: Today's Top Stories ↗

December 20, 2022

Benzinga

Via Benzinga

On A Mission As Top European Player, Galapagos Looks For Acquisition Targets ↗

December 20, 2022

Galapagos NV (NASDAQ: GLPG) is reportedly looking for M&A deals with companies with products still in the preclinical or early stage of development.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 7, 2022 ↗

November 07, 2022

Upgrades

Via Benzinga

After FDA, European Agency Limits Use Of Certain JAK Inhibitors Amid Safety Concerns ↗

October 31, 2022

Via Benzinga

Expert Ratings for Galapagos ↗

October 13, 2022

Over the past 3 months, 4 analysts have published their opinion on Galapagos (NASDAQ:GLPG) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

3 Biotech Stocks to Sell in October ↗

September 29, 2022

These biotech stocks to sell are at a cross roads with their businesses with few growth catalysts ahead amid this turbulent market.

Via InvestorPlace

Lyft, DoorDash, Expedia And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

August 05, 2022

Atlas Corp. (NYSE: ATCO) rose 21.4% to $14.06 in pre-market trading after the company said it received a non-binding proposal from Poseidon Acquisition Corp. to acquire all outstanding common shares of...

Via Benzinga

The Daily Biotech Pulse: Precision BioSciences Inks Gene Editing Pact, Athira Pharma's Alzheimer's Candidate Fails, Enanta Sues Pfizer Over COVID-19 Antiviral ↗

June 22, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022 ↗

September 09, 2022

Upgrades

Via Benzinga

RBC Expects Business Development To Unlock This Pharma Stock's Balance Sheet Value ↗

May 09, 2022

RBC Capital Markets views Galapagos' NV (NASDAQ: GLPG) Q1 Jyseleca revenues in line as the story focuses on whether new leadership can unlock value from GLPG's ample balance sheet.

Via Benzinga

The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study ↗

May 05, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For Agios ↗

February 17, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Amylyx's ALS Treatment Regulatory Application To Be Reviewed By FDA Panel...

Via Benzinga

The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More ↗

February 13, 2022

Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news...

Via Benzinga

The Daily Biotech Pulse: Sanofi, Bristol-Myers Squibb Gain On Earnings, Valneva-Pfizer Tout Positive Lyme Disease Vaccine Data, UNITY Biotech Restructures ↗

February 04, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

January 31, 2022

Gainers Madrigal Pharmaceuticals (NASDAQ:MDGL) shares rose 14.9% to $64.8 during Monday's pre-market session. The market value of their outstanding shares is at $1.1...

Via Benzinga

Mid-Afternoon Market Update: US Stocks Turns Lower In Volatile Trading; Nasdaq Tumbles 150 Points ↗

January 27, 2022

US stocks turned lower in another volatile trading session on Thursday despite stronger-than-expected GDP data. The country’s economy grew 6.9% on quarter during the last...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 27, 2022

Gainers Galapagos (NASDAQ:GLPG) stock rose 21.4% to $64.75 during Thursday's regular session. Trading volume for this security as of 12:30 EST is 1.5 million, which is...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Galapagos NV - American Depositary Shares (NQ:GLPG)

All News about Galapagos NV - American Depositary Shares

Starting at $3.75/week.

Subscribe Today